For someone living with endometriosis, the wait for an explanation can stretch across years of painful periods, appointments and missed days at work or school. Researchers have now found a wider set of genetic clues that could help scientists understand why the condition develops.

An international team analysed data from more than one million people across 14 biobanks and identified 58 regions of the genome associated with endometriosis. Twenty-seven of those regions had not previously been recognised, according to the US National Institutes of Health (NIH), which supported the research.

The study, published in Nature Genetics on 20 November, brings together participants from a wider range of ancestral backgrounds than many earlier studies. It offers researchers a map of promising places to investigate, rather than an immediate change to a patient’s appointment or medication.

Why this condition can be so disruptive

Endometriosis occurs when tissue similar to the lining of the uterus grows elsewhere in the body. The World Health Organization (WHO) estimates it affects around one in ten reproductive-age women globally. Transgender men and non-binary people who menstruate can also be affected.

Symptoms vary. Some people experience severe period pain, ongoing pelvic pain, heavy bleeding, pain during sex, bowel movements or urination, fatigue or difficulty conceiving. Others may have few or no symptoms. Pain and fatigue can interfere with school, work and relationships, while repeated consultations and treatment costs can add pressure to families.

WHO notes that diagnosis is often delayed. Symptoms can overlap with other conditions, and access to experienced clinicians and investigations differs between places. Its global estimate for the average time to diagnosis is four to 12 years; that figure is not a Malaysia-specific waiting time.

That is why research into the biology matters. If scientists can identify the processes involved, they can ask more precise questions about how the condition starts and why it affects people differently. Turning those questions into a reliable test or effective medicine, however, takes further studies.

What did the researchers actually find?

The team combined information from biobanks participating in an international research initiative. A biobank is a collection of health and biological information contributed for research. By comparing patterns across a large group, scientists can look for genetic differences that occur more often in people with a condition than in those without it.

The study found 58 genomic regions associated with endometriosis, including 27 that were new to the researchers’ account. A genomic region is a location in DNA; identifying an association there does not automatically identify a single gene that causes the condition. Researchers must still investigate what happens at that location and how it may relate to disease.

The team also examined several kinds of biological data together, an approach often called multiomics. NIH reports that this analysis pointed to 314 genes that may be associated with endometriosis. These are leads for further work, not a list of 314 proven causes.

The researchers additionally reported shared genetic links with 135 other conditions or traits. A shared genetic association does not mean that every person with endometriosis will develop another condition. It gives scientists another way to study processes that may overlap.

Why ancestry matters

Many earlier genetic studies drew mainly on people of European ancestry, with smaller contributions from some East Asian populations, according to NIH. That can leave important gaps when researchers try to understand conditions across the world.

In the new analysis, more than 30% of participants were of non-European ancestry. The team found some associations in people of African and admixed American ancestry that had not been identified before. The paper describes a range of groups, though representation within any one group is not automatically equal.

For patients in Malaysia, a more diverse research base is a useful direction: people here come from many backgrounds. The study does not provide a Malaysia-specific test, estimate an individual Malaysian’s risk or establish that its findings work equally well for every community. More representative research remains important.

What can someone do now?

Anyone whose period pain, pelvic pain or other symptoms disrupt daily life can discuss them with a healthcare professional. A record of when pain occurs, its severity, bleeding and other symptoms may help make the conversation more specific. Symptoms alone cannot confirm the cause.

WHO says a clinician may assess a person’s history and symptoms and use imaging such as ultrasound or MRI. Surgery can sometimes help confirm a diagnosis, but it is not necessarily required before treatment begins. The approach depends on the individual and the services available.

There is currently no definitive cure, but treatment can help manage symptoms. WHO lists pain medicines, hormonal treatments and, for some people, surgery among the options. The right choice depends on symptoms, side effects, preferences, costs and whether pregnancy is desired. Those decisions deserve an individual discussion with a clinician.

Before an appointment, it can also help to note whether symptoms affect sleep, daily activities or bowel and bladder function, and to mention any treatments already tried. These details give a clinician a fuller picture; they are not a substitute for an assessment. If a proposed treatment does not fit a person’s plans or causes difficult side effects, that is a reason to discuss other options with their care team.

Support matters beyond the prescription too. Persistent pain can affect sleep, work and mental wellbeing; WHO notes that support groups and multidisciplinary pain care may help some people alongside medical treatment. Taking pain seriously is an important part of making that care accessible.

The researchers’ next task is to work out which of the genetic signals have useful biological functions and whether any can guide future diagnostics or therapies. For now, the study gives a complicated condition a larger, more diverse set of clues – and offers scientists more informed places to look.

Prepared with AI assistance from linked reporting. The cover is an AI-generated editorial illustration. Spotted something we should correct?

Stay curious. s.